Plain-English translation of NCT02879123 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a follow-up study for people who have received emergency endovascular treatment (a procedure to remove a blood clot blocking an artery in the brain) during an acute stroke. Researchers want to collect standardized recovery information from 5,000 patients at the 3-month mark after treatment to better understand how well this procedure works and what factors affect long-term recovery.
While emergency clot removal is a proven, effective treatment for acute stroke that reduces disability and saves lives, most patients are not systematically followed up at 3 months—a critical time point for understanding true recovery outcomes. This study aims to gather consistent, reliable data on how patients recover after this treatment so doctors can better predict and support patient outcomes.
You likely qualify if…
You likely don't qualify if…
You will be followed up at 3 months after your endovascular stroke treatment, likely through your regular neurology clinic visits or follow-up care appointments. Researchers will collect standardized information about your recovery and neurological improvement using clinical assessments and your medical records—no additional procedures or visits beyond your normal care are required.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
France
Enrollment target
~5,000 participants
Started
November 2015
Primary completion
November 2030
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Raphaël Blanc, MD
Fondation Ophtalmologique Adolphe de Rothschild
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.